KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 108 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,270,103 | +23.4% | 130,691 | 0.0% | 1.01% | +21.6% |
| Q2 2023 | $1,840,129 | +50.6% | 130,691 | +15.1% | 0.83% | +65.4% |
| Q1 2023 | $1,221,690 | -66.9% | 113,540 | -67.2% | 0.50% | -4.2% |
| Q4 2022 | $3,689,000 | -28.2% | 346,500 | -27.8% | 0.52% | -53.7% |
| Q3 2022 | $5,140,000 | 0.0% | 480,000 | 0.0% | 1.13% | +93.7% |
| Q2 2022 | $5,140,000 | +7.7% | 480,000 | 0.0% | 0.58% | -47.2% |
| Q1 2022 | $4,771,000 | +637.4% | 480,000 | +772.7% | 1.11% | +539.9% |
| Q4 2021 | $647,000 | -88.5% | 55,000 | -88.9% | 0.17% | -83.6% |
| Q3 2021 | $5,646,000 | -18.2% | 495,748 | 0.0% | 1.06% | -11.3% |
| Q2 2021 | $6,905,000 | -24.7% | 495,748 | 0.0% | 1.19% | -28.5% |
| Q1 2021 | $9,176,000 | +4.8% | 495,748 | 0.0% | 1.67% | -1.1% |
| Q4 2020 | $8,759,000 | +15.3% | 495,748 | 0.0% | 1.69% | +1.3% |
| Q3 2020 | $7,594,000 | -39.9% | 495,748 | 0.0% | 1.67% | -45.6% |
| Q2 2020 | $12,631,000 | +64.6% | 495,748 | 0.0% | 3.06% | +51.3% |
| Q1 2020 | $7,674,000 | – | 495,748 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |